How cancer develops and responds to treatment depends not only on the tumour cells themselves but also on the complex ecosystem of surrounding immune cells, blood vessels, and connective tissue. In B-…
Edit
EMBL and Merck are bringing back the European Researchers’ Night to Heidelberg on 25 September 2026, with hands-on science, lab tours, art, and activities for all ages.
Edit
Epitome Therapeutics, a new EMBL spin-off, translates epigenome editing research into precision medicines. Co-founded by EMBL group leader Jamie Hackett, the company builds on pioneering research from…
Edit
EMBL Hamburg researchers and their collaborators have gained new insights into how the influenza A virus reprograms cellular machinery by tracking molecular interactions directly inside infected cells…
Edit
Researchers have designed synthetic and inducible proteins that bind to bright fluorescent dyes with high specificity and affinity, significantly expanding the toolkit for multicolour imaging of prote…
Edit
Members of the McCarthy Team at EMBL Grenoble talk about BSxCuBE-Web, a web-based interface to automate BioSAXS experiments, and how the ARISE programme contributed to this project.
Edit
Scientists have shown how the boundaries of biological tissues create geometric constraints that lead cells to orient in a magnet-like manner, giving rise to structure and order inside developing embr…
Edit
EMBL’s 2025 annual report is now online, sharing achievements across its five missions, along with key facts and figures from the year.
Edit
New EMBL-led research identifies a robust gut microbiome signature linked to colorectal cancer, consistent across populations, sequencing methods & age groups — detectable even in early-stage disease …
Edit
The Papp team at EMBL Grenoble has developed EasyGrid and EasyGrid Control, unique instruments that automate sample preparation and quality control for cryo-electron microscopy, cryo-electron tomograp…
Edit